Tango Therapeutics Cash Flow Statement (2020-2026) | TNGX

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-19.59M-22.05M-25.21M-24.86M-29.05M-29.11M-28.01M-20.75M-22.26M-30.73M-37.91M-25.55M-29.17M-37.67M-39.88M-38.85M15.88M-38.75M-45.51M-55.34M
Depreciation and Depletion (Quarter)
0.20M0.26M0.30M0.32M0.42M0.57M0.60M0.58M0.61M0.62M0.60M0.66M0.64M0.60M0.60M0.60M0.60M0.48M0.50M0.40M
Share-based Compensation (Quarter)
3.43M2.26M3.21M3.42M3.81M3.79M4.22M5.12M4.86M4.88M6.72M7.54M7.18M7.46M7.25M6.57M6.62M5.98M77.10M16.89M
Cash from Operations (Quarter)
-21.49M-16.90M-29.66M-31.54M-19.61M-28.27M-34.91M-24.47M-31.14M-27.47M-37.86M-23.61M-33.39M-36.65M-41.70M-36.52M-30.95M-29.72M-44.36M-38.87M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.89M-0.88M0.74M-2.36M-1.37M-1.20M-1.19M-0.86M-0.64M-0.72M-0.56M-0.77M-1.12M-0.94M
Amortization of Deferred Charges (Quarter)
0.26M0.32M0.36M0.37M0.80M0.88M0.88M0.90M0.91M0.91M0.93M0.93M0.94M0.95M1.01M1.02M0.97M0.96M0.97M0.99M
Depreciation & Amortization (CF) (Quarter)
0.20M0.26M0.30M0.32M0.42M0.57M0.60M0.58M0.61M0.62M0.60M0.66M0.64M0.60M0.60M0.60M0.60M0.48M0.50M0.40M
Change in Working Capital
Change in Receivables (Quarter)
-2.00M
Change in Account Payables (Quarter)
-1.88M0.36M-0.36M-2.00M4.49M-1.04M1.55M-1.21M-1.96M-0.09M1.04M-2.77M3.05M-2.51M1.63M-0.88M-0.34M-1.23M1.78M-0.76M
Change in Accured Expenses (Quarter)
3.87M0.04M-0.16M4.42M1.59M1.78M-6.70M2.46M-1.78M4.00M-1.61M3.02M-1.77M1.49M-6.12M1.14M1.60M4.49M-8.69M5.90M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
1.21M11.48M3.69M-11.22M8.84M-18.17M2.78M-4.24M-0.39M4.08M-0.36M-2.14M1.49M0.64M-0.78M-0.81M-60.79M2.30M5.19M
Investing Activities
Capital Expenditures (Quarter)
0.43M-0.26M0.50M-0.51M6.66M1.04M0.62M0.66M0.02M-1.26M-0.04M0.55M-0.55M0.79M0.05M0.26M-0.08M0.08M-0.01M0.15M
Change in Acquisitions & Divestments (Quarter)
30.42M59.87M44.41M53.23M62.96M81.99M84.70M84.13M99.59M85.10M109.25M61.63M72.15M84.73M77.81M41.34M65.97M39.52M64.05M73.10M
Cash from Investing Activities (Quarter)
-152.21M-45.21M-11.72M35.49M15.23M-12.61M31.55M32.69M-56.66M33.85M-11.20M12.70M32.57M52.06M30.60M16.78M47.48M-135.72M9.63M-445.97M
Financing Activities
Other financing activities (Quarter)
0.10M0.27M0.07M0.00M17.61M20.62M
Cash from Financing Activities (Quarter)
327.78M-0.12M0.26M0.72M0.11M0.53M0.07M0.59M80.28M1.47M42.98M1.31M2.40M0.97M0.00M0.58M2.54M219.38M79.85M672.57M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
41.72M
Additional items
Change in Cash (Quarter)
154.07M-62.23M-41.12M4.67M-4.27M-40.34M-3.28M8.80M-7.52M7.85M-6.08M-9.60M1.58M16.38M-11.10M-19.16M19.07M53.94M45.12M187.73M
Free Cash Flow (Quarter)
-21.92M-16.64M-30.16M-31.03M-26.27M-29.31M-35.53M-25.14M-31.15M-26.20M-37.82M-24.16M-32.84M-37.44M-41.75M-36.77M-30.87M-29.80M-44.35M-39.02M
Net Cash Flow (Quarter)
154.07M-62.23M-41.12M4.67M-4.27M-40.34M-3.28M8.80M-7.52M7.85M-6.08M-9.60M1.58M16.38M-11.10M-19.16M19.07M53.94M45.12M187.73M